Amgen (AMGN) Change in Acquisitions & Divestments (2009 - 2023)

Amgen has reported Change in Acquisitions & Divestments for 15 years, with the latest figure at -$2.0 million in Q4 2023.

• On a quarterly basis, Change in Acquisitions & Divestments fell 100.3% year-over-year to -$2.0 million in Q4 2023; TTM through Sep 2024 was -$2.0 million, a 100.11% decrease from a year earlier, with the FY2023 full-year figure at $1.1 billion, changed 0.27% from the prior year.
• Change in Acquisitions & Divestments was -$2.0 million for Q4 2023 at Amgen, down from $1.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $10.5 billion in Q1 2019, with the low at -$2.0 million in Q4 2023.
• Average Change in Acquisitions & Divestments over 5 years is $1.9 billion, with a median of $1.1 billion recorded in 2023.
• The sharpest annual moves came in 2021 and 2023: Change in Acquisitions & Divestments surged 140000.0% in 2021, then sank 100.3% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $2.1 billion in 2019, then declined by 15.33% to $1.8 billion in 2020, then slumped by 49.33% to $904.0 million in 2021, then dropped by 25.55% to $673.0 million in 2022, then tumbled by 100.3% to -$2.0 million in 2023.
• The last three Change in Acquisitions & Divestments figures came in at -$2.0 million (Q4 2023), $1.0 million (Q2 2023), and $1.1 billion (Q1 2023), per Business Quant data.